Product Information
ELURYNG VAGINAL RING is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $46.3541 per EA under NDC 65162046935. Its NADAC has been published 346 times since Feb 19, 2020.
FDA first approved this application on Dec 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.015; .12 mg/d; mg/d
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162046935
Classification
Generic
Dosage Form
RING
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; ETONOGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA210830FDA Approved
12/11/2019
TE Code
AB
On Market Since
12/16/2019
Price Statistics
The NADAC for ELURYNG VAGINAL RING has been published 346 times since Feb 19, 2020, and over the history we have for it it has declined 57.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.3541 per EA |
|---|---|
| All-time high | $122.8691 (Apr 15, 2020) |
| All-time low | $42.5371 (Nov 20, 2024) |
| 52-week high | $50.5133 |
| 52-week low | $46.3541 |
| Median price | $80.2809 |
| Average price | $78.8495 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 346 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Etonogestrel and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Etonogestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ELURYNG VAGINAL RING?
The current National Average Drug Acquisition Cost (NADAC) for ELURYNG VAGINAL RING, manufactured by Amneal Pharmaceuticals LLC, is $46.3541 per EA (NDC 65162046935), effective Sep 30, 2026.
How has the price of ELURYNG VAGINAL RING changed over time?
Over the history we have for it, the NADAC for ELURYNG VAGINAL RING has declined 57.0%. It has been tracked across 346 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for ELURYNG VAGINAL RING?
Since Feb 19, 2020, the NADAC for ELURYNG VAGINAL RING has ranged from a low of $42.5371 (Nov 20, 2024) to a high of $122.8691 (Apr 15, 2020), with a median of $80.2809 per EA.
Are there cheaper alternatives to ELURYNG VAGINAL RING?
No other NADAC-published product currently shares the active ingredient and strength of ELURYNG VAGINAL RING in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ELURYNG VAGINAL RING?
ELURYNG VAGINAL RING (NDC 65162046935) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.